These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 9603157

  • 21. Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
    Wingard JR, Herbrecht R, Mauskopf J, Schlamm HT, Marciniak A, Roberts CS.
    Transpl Infect Dis; 2007 Sep; 9(3):182-8. PubMed ID: 17605747
    [Abstract] [Full Text] [Related]

  • 22. [A case of resistant pulmonary and cerebral aspergillosis successfully treated with voriconazole].
    Uçan ES, Avkan Oğuz V, Güngör O, Gülşen A, Uğural Sezak N, Tertemiz KC, Ceylan E, Kargi A, Balci P, Ada E, Sanli A.
    Tuberk Toraks; 2006 Sep; 54(1):75-9. PubMed ID: 16615023
    [Abstract] [Full Text] [Related]

  • 23. Treatment of invasive aspergillosis with itraconazole in a patient with chronic granulomatous disease.
    van 't Wout JW, Raven EJ, van der Meer JW.
    J Infect; 1990 Mar; 20(2):147-50. PubMed ID: 2156938
    [Abstract] [Full Text] [Related]

  • 24. Chronic granulomatous disease presenting with disseminated intracranial aspergillosis.
    Alsultan A, Williams MS, Lubner S, Goldman FD.
    Pediatr Blood Cancer; 2006 Jul; 47(1):107-10. PubMed ID: 15931655
    [Abstract] [Full Text] [Related]

  • 25. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
    Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B, Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group.
    N Engl J Med; 2002 Aug 08; 347(6):408-15. PubMed ID: 12167683
    [Abstract] [Full Text] [Related]

  • 26. Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature.
    Meyer M, Waldvogel S, Chalandon Y, Bongiovanni M, Pache JC, Van Delden C.
    Scand J Infect Dis; 2007 Aug 08; 39(8):731-3. PubMed ID: 17654353
    [Abstract] [Full Text] [Related]

  • 27. Secondary prophylaxis with voriconazole in a leukemic patient with pulmonary aspergillosis.
    Uriz J, de Andoin NG, Calvo C, Landa J, Onate E, Nogues A, Guerrero R.
    Pediatr Infect Dis J; 2007 Oct 08; 26(10):971-2. PubMed ID: 17901816
    [No Abstract] [Full Text] [Related]

  • 28. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
    Chandrasekar PH, Cutright JL, Manavathu EK.
    Clin Microbiol Infect; 2004 Oct 08; 10(10):925-8. PubMed ID: 15373889
    [Abstract] [Full Text] [Related]

  • 29. Multidrug resistance in Aspergillus fumigatus.
    Warris A, Weemaes CM, Verweij PE.
    N Engl J Med; 2002 Dec 26; 347(26):2173-4. PubMed ID: 12501236
    [No Abstract] [Full Text] [Related]

  • 30. Voriconazole versus amphotericin B for invasive aspergillosis.
    Blot F, Edé C, Nitenberg GM.
    N Engl J Med; 2002 Dec 19; 347(25):2080-1; author reply 2080-1. PubMed ID: 12490695
    [No Abstract] [Full Text] [Related]

  • 31. An update on the use of antifungal agents.
    Martinez R.
    J Bras Pneumol; 2006 Dec 19; 32(5):449-60. PubMed ID: 17268750
    [Abstract] [Full Text] [Related]

  • 32. Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection.
    Segal BH, Barnhart LA, Anderson VL, Walsh TJ, Malech HL, Holland SM.
    Clin Infect Dis; 2005 Jun 01; 40(11):1684-8. PubMed ID: 15889369
    [Abstract] [Full Text] [Related]

  • 33. [Successful treatment by voriconazole for pulmonary aspergilloma of elderly patient].
    Hashimoto M, Honda Y, Fujishima T.
    Nihon Kokyuki Gakkai Zasshi; 2007 Dec 01; 45(12):957-61. PubMed ID: 18186242
    [Abstract] [Full Text] [Related]

  • 34. Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.
    Shouldice E, Fernandez C, McCully B, Schmidt M, Fraser R, Cook C.
    J Pediatr Hematol Oncol; 2003 Sep 01; 25(9):732-4. PubMed ID: 12972810
    [Abstract] [Full Text] [Related]

  • 35. Adjuvant endobronchial amphotericin B for refractory invasive pulmonary aspergillosis: evidence is scarce but promise does exist.
    Stratakos G, Zakynthinos S.
    Respiration; 2007 Sep 01; 74(6):609-10. PubMed ID: 18037812
    [No Abstract] [Full Text] [Related]

  • 36. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
    Patterson TF, Boucher HW, Herbrecht R, Denning DW, Lortholary O, Ribaud P, Rubin RH, Wingard JR, DePauw B, Schlamm HT, Troke P, Bennett JE, European Organization for Research and Treatment of Cancer (EORTC) Invasive Fungal Infections Group (IFIG), Pfizer Global Aspergillus Study Group.
    Clin Infect Dis; 2005 Nov 15; 41(10):1448-52. PubMed ID: 16231256
    [Abstract] [Full Text] [Related]

  • 37. Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight.
    Frankenbusch K, Eifinger F, Kribs A, Rengelshauseu J, Roth B.
    J Perinatol; 2006 Aug 15; 26(8):511-4. PubMed ID: 16871222
    [Abstract] [Full Text] [Related]

  • 38. Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?
    Pagano L, Valentini CG, Fianchi L, Caira M.
    J Chemother; 2011 Feb 15; 23(1):5-8. PubMed ID: 21482486
    [Abstract] [Full Text] [Related]

  • 39. Disseminated invasive aspergillosis in a patient with acute leukaemia.
    Gottfredsson M, Steingrímsdóttir H.
    Acta Biomed; 2006 Feb 15; 77 Suppl 2():10-3. PubMed ID: 16918060
    [Abstract] [Full Text] [Related]

  • 40. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
    Walsh TJ, Lutsar I, Driscoll T, Dupont B, Roden M, Ghahramani P, Hodges M, Groll AH, Perfect JR.
    Pediatr Infect Dis J; 2002 Mar 15; 21(3):240-8. PubMed ID: 12005089
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.